ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...
Үндсэн зохиолчид: | Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
BMJ Publishing Group
2016
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
-н: Craig, SE, зэрэг
Хэвлэсэн: (2012) -
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
-н: Craig, SE, зэрэг
Хэвлэсэн: (2012) -
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
-н: Schulz, U, зэрэг
Хэвлэсэн: (2013) -
Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
-н: Bratton, D, зэрэг
Хэвлэсэн: (2014) -
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
-н: Ayers, L, зэрэг
Хэвлэсэн: (2009)